Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identification of ZBTB7A cistrome and transcriptome profiles in VCaP prostate cancer cells

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE123091 | GEO | 2019/09/12

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Identification of ZBTB7A cistrome and transcriptome profiles in VCaP prostate cancer cells

Project description:Identification of ZBTB7A cistrome and transcriptome profiles in VCaP prostate cancer cells

| PRJNA507613 | ENA

Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-02-22 | GSE94959 | GEO

AR binding in prostate cancer cell lines VCaP and VCS2

Project description:This SuperSeries is composed of the SubSeries listed below.

2012-02-01 | GSE32356 | GEO

Prostate cancer stratification using molecular profiles

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-07-30 | E-GEOD-70770 | biostudies-arrayexpress

ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer.

Project description:Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate cancer. NEPC is characterized by the loss of androgen receptor (AR) signaling and transdifferentiation toward small-cell neuroendocrine (SCN) phenotypes, which results in resistance to AR-targeted therapy. NEPC resembles other SCN carcinomas clinically, histologically and in gene expression. Here, we leveraged SCN phenotype scores of various cancer cell lines and gene depletion screens from the Cancer Dependency Map (DepMap) to identify vulnerabilities in NEPC. We discovered ZBTB7A, a transcription factor, as a candidate promoting the progression of NEPC. Cancer cells with high SCN phenotype scores showed a strong dependency on RET kinase activity with a high correlation between RET and ZBTB7A dependencies in these cells. Utilizing informatic modeling of whole transcriptome sequencing data from patient samples, we identified distinct gene networking patterns of ZBTB7A in NEPC versus prostate adenocarcinoma. Specifically, we observed a robust association of ZBTB7A with genes promoting cell cycle progression, including apoptosis regulating genes. Silencing ZBTB7A in a NEPC cell line confirmed the dependency on ZBTB7A for cell growth via suppression of the G1/S transition in the cell cycle and induction of apoptosis. Collectively, our results highlight the oncogenic function of ZBTB7A in NEPC and emphasize the value of ZBTB7A as a promising therapeutic strategy for targeting NEPC tumors.

| S-EPMC10090553 | biostudies-literature

Prostate cancer stratification using molecular profiles

Project description:This SuperSeries is composed of the SubSeries listed below.

2015-07-30 | GSE70770 | GEO

Profiles of prostate cancer cell lines

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-09-21 | GSE87153 | GEO

Identification of NEDD9 regulated genes in VCaP prostate cancer cells

Project description:NEDD9 gene (Neural precursor Expressed, Developmentally Down-regulated 9) encodes a member of the Cas family of signaling transduction molecules, which is a non-catalytic focal adhesion protein phosphorylated by FAK and Src and functions as a signaling hub to regulate downstream signaling, such as the AKT pathway. In cancers, NEDD9 regulates cell migration, epithelial-mesenchymal transition (EMT), invasion, and metastasis. Gene amplification of NEDD9 is commonly found in the advanced metastatic castration-resistant PCa (~3%) and neuroendocrine PCa (~15%), suggesting NEDD9 may play an important role in PCa progression. In order to characterize the global functions of NEDD9 in PCa cells, we performed RNA-seq analyses in VCaP cells (containing NEDD9 gene amplification) stably infected with shRNA against NEDD9 or non-targeting control (NTC).

2021-01-11 | GSE164531 | GEO

AR binding in prostate cancer cell lines VCaP and VCS2

Project description:This SuperSeries is composed of the following subset Series: GSE32344: Expression profilling of prostate cancer VCaP and VCS2 cells GSE32345: Genome-wide maps of AR binding in prostate cancer cell lines VCaP and VCS2 Refer to individual Series

2012-02-01 | E-GEOD-32356 | biostudies-arrayexpress

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-05-30 | E-GEOD-47220 | biostudies-arrayexpress